nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

11.10.2023 | Research

Hematopoietic stem cells suppress proliferation and enhance differentiation of leukemia cells through regulating apoptotic and inflammatory genes

verfasst von: Bo Li, Can Can, Wancheng Liu, Xiaodong Guo, Hanyang Wu, Yihong Wei, Jinting Liu, Xinyu Yang, Wenbo Jia, Daoxin Ma

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 19/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Stem cells are known to play an important role in tumor treatment and many of them have shown tumor-suppressing ability in different cancers; however, whether hematopoietic stem cells (HSCs) have growth-inhibiting effects on leukemia cells has not been fully evaluated. Herein, we aimed to demonstrate the growth-restraining function of HSCs in acute leukemia treatment.

Methods

Cell fusion experiment was conducted by PEG-1500. The viability, proliferation, apoptosis and differentiation of leukemia cells were evaluated by cell counting, CCK-8 and flow cytometry analysis. The morphological changes were imaged using a fluorescence microscope. The expression of genes was detected by quantitative reverse transcription PCR (qRT-PCR).

Results

We observed that HSCs and their lytic extracts had the capability to suppress leukemia cells proliferation, promote apoptosis and especially induce acute myelogenous leukemia (AML) cells differentiation, which might have an effect on differentiation therapy to leukemia especially AML treatment. The expression levels of Bcl-2, Survivin decreased and Bax increased following HSCs extracts treatment. Furthermore, the expression of inflammatory cytokines also changed in AML cells which might have to do with the mechanism of HSCs/extracts suppressing effect.

Conclusion

HSCs and their extracts can suppress the proliferation of leukemia cells and enhance the differentiation of AML cells and using the extracts of HSCs might be a probable therapeutic option for acute leukemia.

Carrelha J, Meng Y, Kettyle LM, Luis TC, Norfo R, Alcolea V, Boukarabila H, Grasso F, Gambardella A, Grover A, Högstrand K, Lord AM, Sanjuan-Pla A, Woll PS, Nerlov C, Jacobsen SEW (2018) Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells. Nature 554(7690):106–111. https://doi.org/10.1038/nature25455. (Epub 2018 Jan 3 PMID: 29298288)CrossRefPubMed

Chen F, Zhou K, Zhang L, Ma F, Chen D, Cui J, Feng X, Yang S, Chi Y, Han Z, Xue F, Rong L, Ge M, Wan L, Xu S, Du W, Lu S, Ren H, Han Z (2013) Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways. Stem Cells Dev. 22(13):1955–1967. https://doi.org/10.1089/scd.2012.0621. (PMID: 23391335; PMCID: PMC3685326)CrossRefPubMedPubMedCentral

Chen YC, Lan YW, Huang SM, Yen CC, Chen W, Wu WJ, Staniczek T, Chong KY, Chen CM (2022) Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model. Stem Cell Res Ther 13(1):235. https://doi.org/10.1186/s13287-022-02910-3.PMID:35659367;PMCID:PMC9166578CrossRefPubMedPubMedCentral

Cordingley FT, Bianchi A, Hoffbrand AV, Reittie JE, Heslop HE, Vyakarnam A, Turner M, Meager A, Brenner MK (1988) Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1(8592):969–971. https://doi.org/10.1016/s0140-6736(88)91782-5. (PMID: 2896830)CrossRefPubMed

Gauthaman K, Yee FC, Cheyyatraivendran S, Biswas A, Choolani M, Bongso A (2012) Human umbilical cord Wharton’s jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem 113(6):2027–2039. https://doi.org/10.1002/jcb.24073. (PMID: 22275115)CrossRefPubMed

Grants JM, Wegrzyn J, Hui T, O’Neill K, Shadbolt M, Knapp DJHF, Parker J, Deng Y, Gopal A, Docking TR, Fuller M, Li J, Boldin M, Eaves CJ, Hirst M, Karsan A (2020) Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice. Blood 135(25):2235–2251. https://doi.org/10.1182/blood.2019003105. (PMID: 32384151)CrossRefPubMed

Grillot-Courvalin C, Brouet JC, Berger R, Bernheim A (1981) Establishment of a human T-cell hybrid line with suppressive activity. Nature 292(5826):844–845. https://doi.org/10.1038/292844a0. (PMID: 6973698)CrossRefPubMed

He N, Feng G, Li Y, Xu Y, Xie X, Wang H, Wang Y, Ou L, Pei X, Liu N, Li Z (2016) Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer. Stem Cell Res Ther 7(1):95. https://doi.org/10.1186/s13287-016-0360-x. (PMID:27460364;PMCID:PMC4962384)CrossRefPubMedPubMedCentral

He K, Qu H, Xu LN, Gao J, Cheng FY, Xiang P, Zhou CQ (2016) Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells. Biosci Rep 36(5):e00378. https://doi.org/10.1042/BSR20160104. (PMID:27377320;PMCID:PMC5025808)CrossRefPubMedPubMedCentral

Hsu HC, Lee YM, Tsai WH, Jiang ML, Ho CH, Ho CK, Wang SY (2002) Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology 63(1):64–69. https://doi.org/10.1159/000065722. (PMID: 12187073)CrossRefPubMed

Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72(2):567–572 (PMID: 3165295)CrossRefPubMed

Huwaikem MAH, Kalamegam G, Alrefaei G, Ahmed F, Kadam R, Qadah T, Sait KHW, Pushparaj PN (2021) Human Wharton’s jelly stem cell secretions inhibit human leukemic cell line K562 in vitro by inducing cell cycle arrest and apoptosis. Front Cell Dev Biol 18(9):614988. https://doi.org/10.3389/fcell.2021.614988. (PMID:33869169;PMCID:PMC8044948)CrossRef

Jiang D, Wu X, Sun X, Tan W, Dai X, Xie Y, Du A, Zhao Q (2022) Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11. J Nanobiotechnology 20(1):29. https://doi.org/10.1186/s12951-021-01206-7. (PMID:35012554;PMCID:PMC8744354)CrossRefPubMedPubMedCentral

Kalamegam G, Sait KHW, Ahmed F, Kadam R, Pushparaj PN, Anfinan N, Rasool M, Jamal MS, Abu-Elmagd M, Al-Qahtani M (2018) Human Wharton’s jelly stem cell (hWJSC) extracts inhibit ovarian cancer cell lines OVCAR3 and SKOV3 in vitro by inducing cell cycle arrest and apoptosis. Front Oncol 7(8):592. https://doi.org/10.3389/fonc.2018.00592.PMID:30581772;PMCID:PMC6293270CrossRef

Knapp DJHF, Hammond CA, Wang F, Aghaeepour N, Miller PH, Beer PA, Pellacani D, VanInsberghe M, Hansen C, Bendall SC, Nolan GP, Eaves CJ (2019) A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data. Blood 133(9):927–939. https://doi.org/10.1182/blood-2018-10-878025. (Epub 2019 Jan 8. PMID: 30622121; PMCID: PMC6396178)CrossRefPubMedPubMedCentral

Kovtonyuk LV, Fritsch K, Feng X, Manz MG, Takizawa H (2016) Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment. Front Immunol 14(7):502. https://doi.org/10.3389/fimmu.2016.00502. (PMID:27895645;PMCID:PMC5107568)CrossRef

Lau CY, Budz-Tymkewycz S, Wang EY, Ishaque A (1984) A mutant human T-cell line producing immunosuppressive factor(s). Cell Immunol 87(1):35–52. https://doi.org/10.1016/0008-8749(84)90128-x. (PMID: 6234996)CrossRefPubMed

Lin HD, Fong CY, Biswas A, Choolani M, Bongso A (2014) Human Wharton’s jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells. Stem Cell Rev Rep 10(4):573–586. https://doi.org/10.1007/s12015-014-9514-3. (PMID: 24789672)CrossRefPubMed

Nowak D, Stewart D, Koeffler HP (2009) Differentiation therapy of leukemia: 3 decades of development. Blood 113(16):3655–3665. https://doi.org/10.1182/blood-2009-01-198911. (Epub 2009 Feb 12. PMID: 19221035; PMCID: PMC2943835)CrossRefPubMedPubMedCentral

Peña-Martínez P, Eriksson M, Ramakrishnan R, Chapellier M, Högberg C, Orsmark-Pietras C, Richter J, Andersson A, Fioretos T, Järås M (2018) Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner. Leukemia 32(3):588–596. https://doi.org/10.1038/leu.2017.261. (Epub 2017 Aug 18. PMID: 28819278; PMCID: PMC5843897)CrossRefPubMed

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660. (Epub 2021 Feb 4 PMID: 33538338)CrossRefPubMed

Wang Y, Fan H, Zhou B, Ju Z, Yu L, Guo L, Han J, Lu S (2012) Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells. Int J Oncol 40(2):370–377. https://doi.org/10.3892/ijo.2011.1232. (Epub 2011 Oct 13 PMID: 22002183)CrossRefPubMed

Westermann F, Kube D, Haier B, Bohlen H, Engert A, Zuehlsdorf M, Diehl V, Tesch H (1996) Interleukin 10 inhibits cytokine production of human AML cells. Ann Oncol 7(4):397–404. https://doi.org/10.1093/oxfordjournals.annonc.a010607. (PMID: 8805932)CrossRefPubMed

Xue SP, Zhang SF, Ma W, Zhang Z, Liu P, Zhao Q, Han D (2006) Erythroid differentiation denucleation factors (EDDFs) function as intrinsic, post-erythropoietin regulators for mammalian erythroid terminal differentiation. Cell Prolif 39(1):61–74. https://doi.org/10.1111/j.1365-2184.2006.00366.x. (PMID:16426423;PMCID:PMC6496009)CrossRefPubMed

Titel: Hematopoietic stem cells suppress proliferation and enhance differentiation of leukemia cells through regulating apoptotic and inflammatory genes
verfasst von: Bo Li
Can Can
Wancheng Liu
Xiaodong Guo
Hanyang Wu
Yihong Wei
Jinting Liu
Xinyu Yang
Wenbo Jia
Daoxin Ma
Publikationsdatum: 11.10.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 19/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-05440-4

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Hematopoietic stem cells suppress proliferation and enhance differentiation of leukemia cells through regulating apoptotic and inflammatory genes